OFEV

Nintedanib · Boehringer Ingelheim Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

38 regulatory and trial events tracked for OFEV, covering 2014-10-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Real-life-persistence to Antifibrotic Treatments